SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.

The company expects to launch its IPO in 4Q18.

In a Thursday announcement, the clinical stage cancer diagnostics company says it intends to use its latest round of funds for business expansion, technology development, talent recruitment and IPO-related expenses to develop end-to-end cancer diagnostic tests.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook